Understanding the Gap Between Efficacy in Randomized Controlled Trials and Effectiveness in Real-World Use of GLP-1 RA and DPP-4 Therapies in Patients With Type 2 Diabetes

CONCLUSIONS
Poor medication adherence is primarily why RW effectiveness is significantly less than RCT efficacy, suggesting an urgent need to effectively address adherence among patients with type 2 diabetes.

Source: Diabetes Care - October 23, 2017 Category: Endocrinology Authors: Carls, G. S.; Tuttle, E.; Tan, R.-D.; Huynh, J.; Yee, J.; Edelman, S. V.; Polonsky, W. H. Tags: Epidemiology/Health Services Research Source Type: research